HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Cancer Adjuvant chemotherapy

Cancer Adjuvant chemotherapy plays a crucial role in the comprehensive treatment of cancer. This therapeutic approach involves the use of additional chemotherapy after the primary treatment, such as surgery, to target any remaining cancer cells. By extending the scope of intervention beyond the initial procedure, adjuvant chemotherapy aims to eradicate potential residual cancer cells and minimize the risk of recurrence.The selection of adjuvant chemotherapy is based on various factors, including the type and stage of cancer, as well as individual patient considerations. Oncologists carefully assess the specific characteristics of the cancer to determine the most effective chemotherapy agents and treatment regimen.The primary goal of adjuvant chemotherapy is to improve long-term outcomes by reducing the likelihood of cancer recurrence. It complements the primary treatment method, addressing microscopic cancer cells that may have escaped initial therapy. This proactive approach enhances the overall effectiveness of cancer treatment and contributes to increased survival rates.While adjuvant chemotherapy has proven to be beneficial in many cases, it is essential to consider individual patient factors and potential side effects. The decision to incorporate adjuvant chemotherapy into a treatment plan is made collaboratively between the patient and their medical team, taking into account the unique aspects of the cancer diagnosis and the patient's overall health.
In conclusion, adjuvant chemotherapy is a valuable component of cancer treatment strategies, working synergistically with primary interventions to improve the chances of long-term success. This approach underscores the complexity and individualized nature of cancer care, emphasizing the importance of tailored treatment plans for each patient.

Committee Members
Speaker at International Conference on Clinical & Translational Oncology 2026 - Yan Leyfman

Yan Leyfman

NYP- Meyer Cancer Center, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Conference on Clinical & Translational Oncology 2026 - Jianhua Luo

Jianhua Luo

University of Pittsburgh School of Medicine, United States
ICTO 2026 Speakers
Speaker at International Conference on Clinical & Translational Oncology 2026 - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Speaker at International Conference on Clinical & Translational Oncology 2026 - Sergey Suchkov

Sergey Suchkov

N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Speaker at International Conference on Clinical & Translational Oncology 2026 - Shinya Tajima

Shinya Tajima

National Hospital Organization Shizuoka Medical Centre, Japan
Speaker at International Conference on Clinical & Translational Oncology 2026 - Nayara Delgado Andre

Nayara Delgado Andre

Federal University of São João del-Rei (UFSJ), Brazil
Tags

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp